{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:56:59Z","timestamp":1780624619530,"version":"3.54.1"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":124,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ebr.2021.100457","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T13:04:28Z","timestamp":1620392668000},"page":"100457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy"],"prefix":"10.1016","volume":"16","author":[{"given":"Ajith","family":"Cherian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharath Chandra","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"Divya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Pavuluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2021.100457_b0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/08880019409140546","article-title":"Interference of high-dose methotrexate in the metabolism of valproate?","volume":"11","author":"Schr\u00f8der","year":"1994","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ebr.2021.100457_b0010","doi-asserted-by":"crossref","unstructured":"Christa P. B\u00e9nit, Charles J. Vecht, Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids, Neuro-Oncology Practice, Volume 3, Issue 4, December 2016, Pages 245\u2013260, https:\/\/doi.org\/10.1093\/nop\/npv038.","DOI":"10.1093\/nop\/npv038"},{"key":"10.1016\/j.ebr.2021.100457_b0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4172\/2157-7609.1000125","article-title":"Methotrexate side effects: review article","volume":"3","author":"Gaies","year":"2012","journal-title":"J Drug Metab Toxicol"},{"key":"10.1016\/j.ebr.2021.100457_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0305-7372(83)80032-2","article-title":"The clinical pharmacology of methotrexate","volume":"10","author":"Schornagel","year":"1983","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ebr.2021.100457_b0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.WCB.0000044631.80210.3C","article-title":"Astrocytes and brain injury","volume":"23","author":"Chen","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.ebr.2021.100457_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2006.08.012","article-title":"Methotrexate induces seizure and decreases glutamate uptake in brain slices: prevention by ionotropic glutamate receptors antagonists and adenosine","volume":"80","author":"Leke","year":"2006","journal-title":"Life Sci"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986421000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986421000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:09:13Z","timestamp":1762906153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986421000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":6,"alternative-id":["S2589986421000319"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2021.100457","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2021.100457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100457"}}